血压自我监测对妊娠期慢性或妊娠期高血压血压控制的影响:BUMP 2 随机临床试验
BUMP 2 随机临床试验在英格兰15家医院产科招募妊娠期慢性高血压或妊娠期高血压患者,比较血压自我监测联合远程监测与常规护理对血压控制的影响。结果显示两组由医护人员测量的平均收缩压无显著差异,自我监测未显著改善诊室血压控制。
要点
- 妊娠期慢性或妊娠期高血压患者中,血压自我监测联合远程监测较常规护理未显著改善诊室血压控制。
- 慢性高血压队列自我监测组与常规护理组平均收缩压分别为133.8 mm Hg与133.6 mm Hg,校正均数差0.03 mm Hg(95%CI -1.73至1.79)。
- 妊娠期高血压队列两组平均收缩压分别为137.6 mm Hg与137.2 mm Hg,校正均数差-0.03 mm Hg(95%CI -2.29至2.24)。
核心结论
- 在妊娠期慢性或妊娠期高血压患者中,血压自我监测联合远程监测与常规护理相比未显著改善诊室血压控制。
研究设计与样本
- 非盲随机临床试验,2018年11月至2019年9月在英格兰15家医院产科招募,最终随访于2020年5月完成。
- 慢性高血压患者(入组至妊娠37周)或妊娠期高血压患者(入组于妊娠20至37周)随机分为自我监测联合常规护理组(n=430)或单纯常规护理组(n=420)。
- 慢性高血压队列454例(平均年龄36岁,入组平均孕周20周),妊娠期高血压队列396例(平均年龄34岁,入组平均孕周33周)。
主要发现
- 慢性高血压队列中,自我监测组与常规护理组平均收缩压分别为133.8 mm Hg与133.6 mm Hg,校正均数差0.03 mm Hg(95%CI -1.73至1.79),无统计学显著差异。
- 妊娠期高血压队列中,自我监测组与常规护理组平均收缩压分别为137.6 mm Hg与137.2 mm Hg,校正均数差-0.03 mm Hg(95%CI -2.29至2.24),无显著差异。
- 自我监测组发生8例严重不良事件(两个队列各4例),常规护理组发生3例(慢性高血压队列2例,妊娠期高血压队列1例)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Inadequate management of elevated blood pressure is a significant contributing factor to maternal deaths. The role of blood pressure self-monitoring in pregnancy in improving clinical outcomes for the pregnant individual and infant is unclear. OBJECTIVE: To evaluate the effect of blood pressure self-monitoring, compared with usual care alone, on blood pressure control and other related maternal and infant outcomes, in individuals with pregnancy hypertension. DESIGN, SETTING, AND PARTICIPANTS: Unblinded, randomized clinical trial that recruited between November 2018 and September 2019 in 15 hospital maternity units in England. Individuals with chronic hypertension (enrolled up to 37 weeks' gestation) or with gestational hypertension (enrolled between 20 and 37 weeks' gestation). Final follow-up was in May 2020. INTERVENTIONS: Participants were randomized to either blood pressure self-monitoring using a validated monitor and a secure telemonitoring system in addition to usual care (n = 430) or to usual care alone (n = 420). Usual care comprised blood pressure measured by health care professionals at regular antenatal clinics. MAIN OUTCOMES AND MEASURES: The primary maternal outcome was the difference in mean systolic blood pressure recorded by health care professionals between randomization and birth. RESULTS: Among 454 participants with chronic hypertension (mean age, 36 years; mean gestation at entry, 20 weeks) and 396 with gestational hypertension (mean age, 34 years; mean gestation at entry, 33 weeks) who were randomized, primary outcome data were available from 444 (97.8%) and 377 (95.2%), respectively. In the chronic hypertension cohort, there was no statistically significant difference in mean systolic blood pressure for the self-monitoring groups vs the usual care group (133.8 mm Hg vs 133.6 mm Hg, respectively; adjusted mean difference, 0.03 mm Hg [95% CI, -1.73 to 1.79]). In the gestational hypertension cohort, there was also no significant difference in mean systolic blood pressure (137.6 mm Hg compared with 137.2 mm Hg; adjusted mean difference, -0.03 mm Hg [95% CI, -2.29 to 2.24]). There were 8 serious adverse events in the self-monitoring group (4 in each cohort) and 3 in the usual care group (2 in the chronic hypertension cohort and 1 in the gestational hypertension cohort). CONCLUSIONS AND RELEVANCE: Among pregnant individuals with chronic or gestational hypertension, blood pressure self-monitoring with telemonitoring, compared with usual care, did not lead to significantly improved clinic-based blood pressure control. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03334149.
引用
- Chappell LC, Tucker KL, Galal U, et al. Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial. JAMA. 2022. PMID: 35503345. doi:10.1001/jama.2022.4726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。